Rothblatt Martine A

United Therapeutics Corp.

Chairperson & CEO, Director

Avg. Two Year Performance

75% Avg. Purchase Return 32% Compound

(3%) Avg. Sale Return (1%) Compound

Holdings: 644.49K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions